Business Wire
-
MEDITECH Introduces Expanse Outreach Portal To Support Laboratory Clients
2/26/2025
MEDITECH today announced the addition of a new web-based Expanse Outreach Portal.
-
Oklo Collaborates With The U.S. DOE And Oak Ridge National Laboratory To Advance Next Generation Materials Development
2/25/2025
Oklo Inc. (NYSE: OKLO) (“Oklo”), an advanced nuclear technology company, has announced its participation in the U.S. Department of Energy (DOE) Voucher Program, which is expected to support the evaluation and testing of advanced structural materials for Oklo’s Aurora powerhouse.
-
Hims & Hers Acquires At-Home Lab Testing Facility, Expanding Capabilities To Ultimately Include Affordable Whole Body Testing For Subscribers
2/19/2025
Hims & Hers Health, Inc., the leading health and wellness platform, today announced its plans to introduce at-home lab testing through its platform.
-
ClearNote Health Earns Approval For Avantect Pancreatic Cancer Test From New York State Department Of Health
2/18/2025
ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced that the New York State Department of Health (NYSDOH) Clinical Laboratory Evaluation Program (CLEP) has approved its Avantect Pancreatic Cancer Test.
-
Hologic Announces FDA Clearance Of Aptima SARS-CoV-2 Assay
2/18/2025
Hologic, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Aptima® SARS-CoV-2 assay, which was first granted Emergency Use Authorization (EUA) status in May 2020.
-
New 'Super Test' For Prostate Cancer Developed In The UK By EDX Medical
2/17/2025
Scientists in Cambridge have developed a new ‘super test’ for prostate cancer in an effort to revolutionise screening and diagnosis of the disease and accelerate personalised treatment for patients.
-
Thermo Fisher Scientific's New Spatial Imaging System Enables Researchers To Generate High-Quality Data, Making It Easier To Enter The Field Of Spatial Tissue Proteomics
2/12/2025
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Invitrogen EVOS S1000 Spatial Imaging System.
-
Kenai Therapeutics Establishes Research Facility At Lilly Gateway Labs
2/12/2025
Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-shelf neuron replacement therapies for neurological conditions, today announced the establishment of the Company’s research and laboratory facilities at Lilly Gateway Labs (Gateway Labs) in San Diego, which is operated in partnership with Alexandria Real Estate Equities, Inc. Kenai was selected to join the Gateway Labs community at the One Alexandria Square Megacampus based on its innovative approach to developing restorative cell therapies for Parkinson’s disease and other neurological diseases.
-
hc1 + Accumen Launches Next Generation Of Clinical Excellence Solutions
2/11/2025
hc1 + Accumen introduced its next-generation Clinical Excellence solutions today, a comprehensive suite of software and services that improve patient health through personalized diagnostic lab testing and optimized blood transfusion management.
-
Molecular Instruments' RNA In Situ Hybridization (RNA-ISH) Technology Enables Breakthrough Laboratory-Developed Tests (LDTs) To Advance Precision Medicine For Inflammatory Skin Disease
2/11/2025
Molecular Instruments, Inc. (MI), a company powering the future of bioimaging, today announced a significant advancement in dermatological diagnostics through the successful development and implementation of novel laboratory-developed tests (LDTs) at the Department of Dermatology at Yale School of Medicine.